文献速递复苏、休克与脓毒症创伤与烧伤

利用PS-OMe miR130捕获细胞外冷诱导RNA结合蛋白:一种对抗失血诱导肺损伤的有前景保护手段

Harnessing extracellular cold-inducible RNA binding protein by PS-OMe miR130: A promising shield against hemorrhage-induced lung injury.
PubMed 文献 · J Trauma Acute Care Surg · 2024-04-30
一句话结论小鼠失血性休克模型中,静脉给予PS-OMe miR130可抑制细胞外冷诱导RNA结合蛋白,减轻全身炎症标志物与肺损伤。

该研究在雄性C57BL6小鼠中经股动脉置管放血至平均动脉压30 mm Hg并维持90分钟诱导失血性休克,随后以乳酸林格液按失血量2倍容量复苏,再经静脉给予磷酸盐缓冲液(溶媒)或62.5 nmol PS-OMe miR130,4小时后取材。结果显示PS-OMe miR130治疗组血清天冬氨酸氨基转移酶、丙氨酸氨基转移酶、乳酸脱氢酶和血尿素氮明显下降,血清IL-6同样降低。肺组织中促炎细胞因子(IL-6、IL-1β、肿瘤坏死因子α)、趋化因子(角质细胞源性趋化因子、巨噬细胞炎症蛋白2)及内皮损伤标志物E-选择素的信使RNA表达显著降低,肺髓过氧化物酶活性受抑,组织学肺损伤明显减轻。作者结论认为PS-OMe miR130通过抑制促炎与损伤,为失血性休克诱导的肺损伤提供有前景的治疗策略。

要点

  • 雄性C57BL6小鼠经股动脉放血至平均动脉压30 mm Hg维持90分钟诱导失血性休克,以2倍失血量乳酸林格液复苏。
  • 复苏后经静脉给予62.5 nmol PS-OMe miR130或磷酸盐缓冲液(溶媒),4小时后取血与肺组织检测。
  • PS-OMe miR130组血清天冬氨酸氨基转移酶、丙氨酸氨基转移酶、乳酸脱氢酶、血尿素氮及IL-6均明显下降。
  • PS-OMe miR130组肺组织IL-6、IL-1β、肿瘤坏死因子α、角质细胞源性趋化因子、巨噬细胞炎症蛋白2及E-选择素信使RNA表达显著降低。
  • PS-OMe miR130组肺髓过氧化物酶活性受抑、组织学肺损伤减轻,淋巴细胞抗原6家族成员G阳性中性粒细胞及TUNEL阳性凋亡细胞显著减少。

适用人群与场景

  • 雄性C57BL6小鼠失血性休克模型:经股动脉置管放血至平均动脉压30 mm Hg并维持90分钟,随后以2倍失血量乳酸林格液复苏。

处置流程与药物剂量

  • 失血性休克诱导:经股动脉置管放血至平均动脉压30 mm Hg,维持90分钟。
  • 复苏:以2倍失血量容量的乳酸林格液进行复苏。
  • 复苏后经静脉给予62.5 nmol PS-OMe miR130或等量磷酸盐缓冲液(溶媒),4小时后取血与肺组织。

研究设计与关键结果

  • 研究类型为小鼠失血性休克模型实验;雄性C57BL6小鼠经股动脉放血至平均动脉压30 mm Hg维持90分钟,以2倍失血量乳酸林格液复苏后静脉给予62.5 nmol PS-OMe miR130或磷酸盐缓冲液(溶媒),4小时后取材。
  • PS-OMe miR130组较溶媒组血清天冬氨酸氨基转移酶、丙氨酸氨基转移酶、乳酸脱氢酶和血尿素氮明显下降。
  • PS-OMe miR130组血清IL-6较溶媒组同样降低。
  • PS-OMe miR130组肺组织促炎细胞因子(IL-6、IL-1β、肿瘤坏死因子α)、趋化因子(角质细胞源性趋化因子、巨噬细胞炎症蛋白2)及内皮损伤标志物E-选择素的信使RNA表达显著降低。
  • PS-OMe miR130组肺髓过氧化物酶活性受明显抑制,组织学评估显示肺损伤明显减轻。
  • PS-OMe miR130组肺内淋巴细胞抗原6家族成员G阳性中性粒细胞及TUNEL阳性凋亡细胞显著减少。

证据类型、等级与局限

  • 证据类型:动物实验(雄性C57BL6小鼠失血性休克模型)。
  • 原文结论认为PS-OMe miR130通过有效抑制促炎与损伤,成为对抗失血性休克诱导肺损伤的有力保护手段,为这类危重临床情况提供有前景的治疗策略。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文结论认为PS-OMe miR130通过抑制促炎与损伤,为失血性休克诱导的肺损伤提供有前景的治疗策略(动物实验结论)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Hemorrhagic shock (HS) poses a life-threatening condition with the lungs being one of the most susceptible organs to its deleterious effects. Extracellular cold-inducible RNA binding protein has emerged as a pivotal mediator of inflammation, and its release has been observed as a case of HS-induced tissue injury. Previous studies unveiled a promising engineered microRNA, designated PS-OMe miR130, which inhibits extracellular cold-inducible RNA binding protein, thereby safeguarding vital organs. In this study, we hypothesized that PS-OMe miR130 serves as a protective shield against HS-induced lung injury by curtailing the overzealous inflammatory immune response.

METHODS: Hemorrhagic shock was induced in male C57BL6 mice by withdrawing blood via a femoral artery cannula to a mean arterial pressure of 30 mm Hg for 90 minutes. The mice were resuscitated with twice the shed blood volume with Ringer's lactate solution. They were then treated intravenously with either phosphate-buffered saline (vehicle) or 62.5 nmol PS-OMe miR130. At 4 hours later, blood and lungs were harvested.

RESULTS: Following PS-OMe miR130 treatment in HS mice, a substantial decrease was observed in serum injury markers including aspartate aminotransferase, alanine transaminase, lactate dehydrogenase, and blood urea nitrogen. Serum interleukin (IL)-6 exhibited a similar reduction. In lung tissues, PS-OMe miR130 led to a significant decrease in the messenger RNA expressions of pro-inflammatory cytokines (IL-6, IL-1β, and tumor necrosis factor α), chemokines (keratinocyte-derived chemokine and macrophage inflammatory protein 2), and an endothelial injury marker, E-selectin. PS-OMe miR130 also produced substantial inhibition of lung myeloperoxidase activity and resulted in a marked reduction in lung injury as evidenced by histological evaluation. This was further confirmed by the observation that PS-OMe miR130 significantly reduced the presence of lymphocyte antigen 6 family member G-positive neutrophils and terminal deoxynucleotidyl transferase dUTP nick end labeling-positive apoptotic cells.

CONCLUSION: PS-OMe miR130 emerges as a potent safeguard against HS-induced lung injury by effectively inhibiting pro-inflammation and injuries, offering a promising therapeutic strategy in such critical clinical condition.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Hu Z, Li J, Jacob A, et al. Harnessing extracellular cold-inducible RNA binding protein by PS-OMe miR130: A promising shield against hemorrhage-induced lung injury. J Trauma Acute Care Surg. 2024. PMID: 38685193. doi:10.1097/TA.0000000000004361

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。